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Abstract:  
The successful high throughput screening of molecule libraries for a specific biological property is one of the main 
improvements in drug discovery. The virtual molecular filtering and screening relies greatly on quantitative structure-
activity relationship (QSAR) analysis, a mathematical model that correlates the activity of a molecule with molecular 
descriptors. QSAR models have the potential to reduce the costly failure of drug candidates in advanced (clinical) 
stages by filtering combinatorial libraries, eliminating candidates with a predicted toxic effect and poor 
pharmacokinetic profiles, and reducing the number of experiments. To obtain a predictive and reliable QSAR model, 
scientists use methods from various fields such as molecular modeling, pattern recognition, machine learning or 
artificial intelligence. QSAR modeling relies on three main steps: molecular structure codification into molecular 
descriptors, selection of relevant variables in the context of the analyzed activity, and search of the optimal 
mathematical model that correlates the molecular descriptors with a specific activity. Since a variety of techniques 
from statistics and artificial intelligence can aid variable selection and model building steps, this review focuses on 
the evolutionary computation methods supporting these tasks. Thus, this review explains the basic of the genetic 
algorithms and genetic programming as evolutionary computation approaches, the selection methods for high-
dimensional data in QSAR, the methods to build QSAR models, the current evolutionary feature selection methods 
and applications in QSAR and the future trend on the joint or multi-task feature selection methods.  
Keywords: Evolutionary computation; Feature extraction; Genetic algorithms; Genetic programming; Molecular 
descriptors; Quantitative structure-activity relationships; QSAR; Variable selection. 
 
 
 
 
 
 
 
 
 
 
  
1. INTRODUCTION  
One of the main improvements of the drug discovery process is represented by the possibility of a 
high throughput screening (HTS) of molecule libraries for a specific biological property [1]. The virtual 
molecular filtering and screening relies greatly on quantitative structure-activity relationships (QSAR), 
proposed by Hansch in the early 1960s [2] and on quantitative structure-property relationships (QSPR). 
QSAR and QSPR generate computational models that predict a biological activity, chemical reactivity or 
physicochemical property from the molecular structure of a chemical compound. In chemistry, 
classification techniques were introduced as pattern recognition techniques, and were developed separate 
from the QSAR of Hansch by researchers from chemometrics such as Jurs [3]. The most general 
mathematical formula of a QSAR model is represented in Eq. 1.  
 
Activity = f(physiochemical properties and/or structural properties) (1)  
 
The use of QSAR models reduces the costly failure of drug candidates in clinical trials by filtering the 
combinatorial libraries, by eliminating the compounds with a predicted toxic effect and poor 
pharmacokinetic properties [4] and by reducing the number of experiments. The difficulty of obtaining 
QSAR models creates the necessity of using methods from various fields such as molecular modeling, 
pattern recognition, machine learning or artificial intelligence [5-8].  
 
A QSAR model can be built by using the following steps: computation of molecular descriptors from 
the molecular structure, selection of the proper variables in the context of the analyzed activity, and 
search of the optimal mathematical model that correlates a specific biological activity with the molecular 
structure. The molecular descriptors are a series of numbers that characterize a molecule and contain the 
information derived from the atomic covalent structure [9]. The activity information is not explicitly 
included in the molecular structure and, therefore, the molecular descriptors [10] are based on different 
molecular properties that range from physicochemical and quantum-chemical to geometrical [11] and 
topological features [12].  
 
The topological descriptors can be extended to macromolecules such as proteins [13] and nucleic 
acids [14, 15] by using the complex network or graph theory considering the nodes as amino acids [16] or 
nucleic acids [17] linked by chemical bonds. The same concept of QSAR can be extended to other 
complex system such as protein-protein interaction [18, 19], drug-protein [20], gene [21] or drug-parasite 
[22] networks by considering proteins, drugs, genes or parasites [23, 24] as the nodes of the network. In 
addition, the amplitudes of the proteome spectrum [25, 26] can be used as nodes of a spectrum graph in 
order to build quantitative proteome-disease relationship (QPDR) or quantitative structure-property 
relationship (QSPR) models [27, 30]. Several previous papers have presented applications in 
bioinformatics, complex networks, artificial intelligence, pharmacology, metabolism drug design or 
medicine [31, 34].  
 
The selection of the molecular descriptors (MDs) and the search for finding the best mathematical 
model between a structure and activity use a large spectrum of methods, such as regression, linear 
discriminant models, artificial neural networks, genetic algorithms or machine learning. In this review we 
overview the main aspects of employing evolutionary computation [35-37] in QSAR research.  
2. EVOLUTIONARY COMPUTATION  
Scientific fields need to tackle with more complex problems as time goes by. In addition to this, the 
time and effort required to solve these problems when using conventional techniques also increase 
remarkably. This can happen either because, initially, the way to find a solution is unknown or due to the 
high complexity of the technique’s implementation.  
 
Many times, however, solutions may be found observing the environment thoroughly. In this sense, 
the survival of species and organisms living in it could be considered the greatest challenge that any 
system may raise; a challenge that nature has solved since the beginning of time, providing a great variety 
of valid solutions. At this point, the following question arises: how does nature find these solutions? This 
has already been answered by Darwin in his Theory of the Evolution of Species: using the mechanism of 
natural selection and with the survival of the fittest individuals [38]. In this context, the human race plays 
a major role due to its predominant position in nature. The reason for this is still unknown, but the most 
widely accepted assumption points toward the human cognitive activity: humans have a higher 
intellectual capacity.  
2.1. Genetic Algorithms and Genetic Programming  
Evolutionary Computation (EC) is inspired in Darwin’s theory. Thus, EC uses the concepts of 
evolution and genetics to provide solutions to problems, obtaining excellent results, especially for 
optimization tasks [35-37]. However, the work of Arthur Samuel and Alan Turing in the 50’s regarding 
whether machines are capable of thinking and whether computers are capable of learning to solve 
problems without being explicitly programmed must also be taken into account.  
 
Broadly speaking, EC methods can be defined as search and optimization techniques that apply 
heuristic rules based on natural evolution principles, that is, algorithms that look for solutions based on 
genetics and evolution properties. Among these properties, the survival of the fittest individuals (which 
implies that the best solutions to a problem will be maintained once they are found) and heterogeneity 
(basic heterogeneity so that algorithms have multiple types of information when generating solutions) 
become particularly relevant.  
2.1.1. Evolutionary Algorithm Performance  
Evolutionary algorithms work following a relatively simple outline, as shown in Fig. (1). The 
algorithm will iteratively refine solutions, progressively approaching a definitive solution to the problem 
to be solved.  
 
 
 
Fig. (1). General outline of performance of an evolutionary algorithm. 
Before implementing the evolutionary process in itself, some important decisions must be made: one 
regarding the encoding, that is, how solutions will be represented, and the other one regarding what is 
known as fitness function, which is what will determine how accurate a solution is.  
 
Regarding the first one, there are mainly two options (see Fig.2): using a list of values (integer, real, 
bits, etc.) of fixed or variable length, or using a tree-shaped representation (in which the leaves usually 
represent the values and the intermediate nodes represent the operators). Depending on the encoding 
strategy chosen, a different technique will be used: Genetic Algorithm (GA) [39] or Genetic 
Programming (GP) [40, 41] respectively. Regardless of the technique used, the solutions obtained by the 
algorithms are known as genetic individuals. Each component (gene for GA or leaf node for PG) 
represents the variables or parameters involved in the problem.  
  
 
 
 
Fig. (2). Encoding of solutions: GA and GP. 
However, maybe the most critical part of implementing an evolutionary algorithm is the definition of 
the fitness function. This function will determine the accuracy of an individual, that is, how good it is. 
Therefore, each individual will be evaluated and rated with a real value. This function is responsible for 
guiding the search process towards one direction or another. Since this function is responsible for 
determining the goodness of each solution, this is feature is specific to the problem to be solved.  
 
Through the application of the different genetic operators, crossover and mutation, the solutions will 
be evolved. These mechanisms simulate the analogue processes of sexual and asexual reproduction that 
take place in nature. Subsequently, each step involved in this kind of algorithm will be discussed.  
2.1.2. Initialization  
The power of evolutionary algorithms lies in the large-scale parallel exploration of search space. Thus, 
multiple solutions representing the population will co-exist, each one exploring a region of the search 
space. The size of the population, in general, will remain stable along the whole process and the 
population will change as the generations go by. These changes will be directed by the fitness function in 
such a way that the different solutions meet constantly the global solution. 
2.1.3. Selection  
Selection algorithms will choose which individuals will have the opportunity to reproduce or not, 
imitating nature's work. Accordingly, more opportunities will be given to the fittest individuals. It is clear 
then that selecting an individual will be related to its fitness value. However, less fit individuals should 
not be completely discarded: not including a part of them in this process would cause the population to 
become uniform in few generations.  
 
Although there exist several selection algorithms, one of the best known ones may be the roulette-
wheel selection algorithm (see Fig. 3), also called fitness proportional selection. In this algorithm, a 
proportion of the wheel is assigned to each of the possible selections based on their fitness value, being 
the sum of all percentages one unit. Hence, the best individuals will be assigned a bigger roulette-wheel 
proportion than the weakest ones, being less likely to be eliminated. In order to select an individual, a 
random number is generated within the interval [0,1], selecting the individual that corresponds to it. Thus, 
the selection is made in a similar way to how a roulette wheel is rotated.  
  
 
 
 
Fig. (3). Roulette-wheel selection.  
2.1.4. Crossover  
Once the individuals that will take part in the reproduction are selected, they are recombined to 
produce the offspring that will be inserted into the next generation. This mechanism is highly relevant for 
the transition between generations, being the usual crossover rates around 90%. The main idea of 
crossover is based on the fact that if two individuals, properly adapted to the environment, are selected 
and the offspring obtained share genetic information of both, it is likely that the inherited information is 
quite the cause of their parents' goodness. Since they share the good features of two individuals, the 
offspring, or at least part of them, should have better characters than each parent separately.  
 
Different crossover operators will be used for GA and GP. In the case of GA, there exist numerous 
crossover algorithms, being maybe the following the most widespread ones: 1-point Crossover, 2-point 
Crossover and uniform Crossover (see Fig. 4). Regarding GP, the most extended crossover 
implementation is the exchange of sub-trees (see Fig. 5). In the 1-point crossover, once two individuals 
are chosen, their chromosomes are cut at an arbitrarily selected site in order to generate two segments that 
combine the head and tail of the parents as shown below. Hence, both descendants inherit genetic 
information from their parents. The 2-point crossover is similar to the 1-point crossover but performing 
two cuts. Thus, the offspring are generated by choosing the central segment of one of the parents and the 
lateral segments of the other parent.  
 
 
 
Fig. (4). Crossover operator in genetic algorithms. 
 
 
  
 
 
 
Fig. (5). Crossover operator in genetic programming. 
Finally, the uniform crossover is totally different from the previous implementations. In this case, 
each gene of the offspring has the same likelihood of belonging to one or the other parent. Although there 
exist multiple implementations of this type of crossover, a crossover mask with binary values is always 
used. When there is a “1” in one of the mask positions, the gene located at that same position in one of the 
offspring is copied from the first parent. Otherwise, that is, when there is a “0”, the gene is copied from 
the second parent. To generate the second offspring, there are two possibilities: either the parents' roles 
are exchanged or the interpretation of ones and zeros of the crossover mask is inverted. In the case of GP, 
the genetic recombination is generally performed by first choosing a non-terminal node from each parent 
and then exchanging the sub-trees hanging from these nodes.  
2.1.5. Mutation  
The mutation operator, which is generally used in combination with the crossover operator, implies a 
modification of the value of one of the individual’s genes or nodes. After the crossover has been 
performed, one or both of the offspring obtained will be mutated depending on a probability, Pm. This 
way, a behavior that occurs in Nature is reproduced: when the offspring are generated there is always 
some sort of error, normally without any effect on the transmission of the genetic information from 
parents to offspring. Occasionally, the mutation provokes a reduction in the fitness value of the individual 
(which might be rectified in successive generations). Nevertheless, the new information implies an 
important increase in the goodness of the solutions or should be taken into account for an improved 
solution in future generations. In general, the mutation is assigned a quite low probability, that is, less 
than 1%. This is mostly due to the fact that individuals tend to have a lower fitness after mutation.  
 
Once more, the implementation of the mutation operator depends on the type of encoding used. In the 
case of GA, mutation usually involves randomly modifying the value of one or more genes or replacing a 
gene (see Fig. 6). In contrast, if using GP, the mutation operator can involve simple mutations (functional 
or terminal) or subtree mutations (see Fig. 7).  
 
 
 
Fig. (6). Mutation operator in genetic algorithms.  
 
  
 
 
 
Fig. (7). Mutation operator in genetic programming.  
2.1.6. Stopping Criterion  
As mentioned before, solutions evolve through a highly iterative mechanism. Hence, there must exist 
a criterion that determines when the execution has concluded. Although there are different possibilities, 
below, the most frequently used are described:  
 
 The fittest individuals that are part of the population represent solutions good enough to solve the 
problem.  
 
 The population has converged, that is, the population has become very much alike. When this 
happens, the average goodness of the population is close to the goodness of the fittest individual.  
 
 The difference between the best solutions from subsequent generations is very small. In the best 
possible scenario, this may mean that the population has already attained a global solution or, in 
contrast, that the algorithm has fallen into a local minimum.  
 
 A fixed maximum number of generations has been reached.  
 
After introducing main ideas behind GAs and GP, the next step is the setup of these two techniques by 
translating the QSAR problems into evolutionary terms. First of all, when GAs are used, two main 
approaches could be used to address the variable selection process. In the first one, the members of the 
population (chromosomes) will encode all the existing features as bit strings. Each bit will represent the 
either presence or absence of the feature, so if a bit is “active” (has a value 1) it will mean that the 
corresponding feature will take into account the next process (classification, ...). On the other hand, if the 
bit is “inactive” (has a value 0) the corresponding featuring will be discarded.  
 
Another possible codification is obtained when each gene fully represents the feature and not only its 
presence/absence status, for example with an index, a character string with its name, while the 
chromosome length will inform about the total number of features selected. Here, fixed or variable-length 
genetic individuals could be used. In both codifications, the fitness function consists of the error of the 
models over the training data, based on the variables selected by the GA.   
In the case that we use a GP-based codification that approach could be extended, allowing the genetic 
individuals to express a rule to perform the classification. In this case, the leaf-nodes in the best tree will 
represent the selected features. Furthermore, an expert would provide the different operators allowed and 
set the valid intervals to the constants used to perform comparisons between features values. It will allow 
the construction of more concrete and precise rules.  
3. QSAR  
QSARs are the final result of the process that starts with a suitable description of molecular structures 
and ends with some inference, hypothesis, and prediction on the properties of molecules in 
environmental, biological, and physicochemical systems in analysis [42].  
 
The chemical structure is susceptible of many numerical representations, commonly known as 
molecular descriptors or MDs. These MDs map the structure of the molecules into a set of numerical or 
binary values that characterize specific molecular properties which can explain an activity. MDs are based 
on several different theories (quantum-chemistry, information theory, organic chemistry, graph theory, 
etc.) and are used to model several different properties of chemicals in many scientific fields (toxicology, 
analytical chemistry, physical chemistry, and medicinal, pharmaceutical, and environmental chemistry). 
Just to have an idea of the number of available MDs, the books Molecular Descriptors for 
Chemoinformatics and Molecular Topology collect definitions, formulas, and short comments of over 
30,000 MDs known in chemical literature up to 2008 [43-50].  
 
Depending on whether the included information is about the 3D orientation or conformation of 
molecules, the MDs are grouped into 2D and 3D QSAR descriptors. The 2D QSAR group contains the 
following: 
 
 constitutional descriptors: molecular weight, total number of atoms in the molecule and number of 
atoms of different identity, total number of single, double, triple or aromatic type bonds, as well as 
number of aromatic rings;  
 
 electrostatic and quantum-chemical descriptors that capture information on the electronic nature of the 
molecule, including descriptors containing information on atomic net and partial charges, molecular 
polarizability [51];  
 
 topological descriptors: they treat the molecular structure as a graph where the nodes are the atoms 
and the connections are the chemical bonds; this group includes the Randiindices [52] (sum of 
geometric averages of edge degrees of atoms with paths of given lengths), Wiener index [53] (the total 
number of bonds in the shortest paths between all pairs of non-hydrogen atoms), Balaban’s index [54], 
Kier and Hall indices [55] and Gálvez indices [56], Diudea’s TI [57], new distance TI [58], 
Trinajstic’s TI [59], Pogliani’s valence TI [60], Bonchev’s information TI [61], Kier’s 
electrotopological state [62], Hosoya’s TI [63];  
 
 geometrical descriptors: information about molecular surface from the atomic van der Waals areas 
and their overlap, molecular volume, principal moments of inertia and gravitational indices, 
shadow areas, total solvent-accessible surface area [64]; 
 
 fragment-based descriptors and molecular fingerprints: they are based on the substructural motifs 
such as BCI fingerprints [65], fast random elimination of descriptors/substructure keys 
(FRED/SKEYS) [66] or hologram QSAR (HQSAR) [67];  
 
 topological index-based pharmacophores: descriptors for sub-structural patterns (topological 
pharmacophores) that are linked with the biological property of the molecules [68].  
  
The 3D QSAR descriptors can be alignment-dependent or alignment-independent. The first group is 
based on different computational methods due to superimposing structures in space such as the following: 
 
 comparative molecular field analysis (CoMFA) is using the electrostatic (Coulombic) and steric 
(van der Waals) energy fields [69];  
 
 comparative molecular similarity indices analysis (CoMSIA) [70] is similar with CoMFA but it 
uses a Gaussian-type function as potential function.  
 
The alignment-independent 3D QSAR MDs are invariant to molecule rotation and translation in 
space, no superposition of compounds being required. They contain the following MDs: comparative 
molecular moment analysis (CoMMA) [71] descriptors that use the second-order moments of the mass 
distribution and charge distributions; weighted holistic invariant molecular (WHIM) descriptors [72] and 
molecular surface WHIM [73] descriptors that provide the invariant information by applying principal 
component analysis (PCA) on the centered coordinates of the atoms that constitute the molecule; VolSurf 
descriptors [74] are based on probing the grid around the molecule with specific probes (for example, 
hydrophobic interactions or hydrogen bond acceptor or donor groups); grid-independent descriptors 
(GRIND) [75] that overcome the problems with interpretability, which are common in alignment-
independent descriptors.  
 
There are many applications that can generate hundreds or thousands of different MDs such as 
MARCH-INSIDE [76], S2SNet [30], Dragon [77]or TOPS-MODE [78]. Only a couple of these 
descriptors can be linked with a specific molecular activity and many of them are intercorrelated. In 
addition, the use of a large MD set requires a large dataset in order to provide a good model. The 
inclusion of non-relevant variables, redundant information and highly correlated variables in the model 
usually leads to overfitting and lack of interpretability for the final QSAR model [79-81]. Consequently, 
most of the QSAR applications are based on high-dimensional multivariate data and require performing 
variable selection in order to find the best QSAR model.  
3.1. Why we Need Variable Selection in QSAR  
At the inaugural lecture of the 18
th
 EuroQSAR Symposium, Professor Hugo Kubinyi differentiated 
between “good” and “poor” QSARs based on four key elements (see Table1): i) nature of the variables or 
parameters; ii) number of variables to select; iii) number of variables in the model; and iv) the predictive 
ability of the model and the way it is evaluated [79]. Depending on the nature of the variables used, the 
final relationship can be not necessarily causative and consequently, the model lacks biophysical 
meaning, which may lead to misleading interpretations [82, 83]. Equally pathological is the presence of 
too many variables at the selection phase or in the final model. In both cases, there is a high probability of 
obtaining chance correlations, overfitted models, or in the best case, just lack of interpretability of the 
model. Equally determinant for the reliability of the QSAR model derived is its predictive ability and the 
way it is evaluated. Cross-validation (CV), using the original variables (leave-one-out CV, leave-many-
out CV) is insufficient for model validation [84]. Yscrambling [85], either using the original variables or 
after performing variable selection, may be misleading. Leave-one-out CV with new variable selection in 
every CV run is misleading in larger data sets [79, 86]. Thus, the leave-many-out (up to 30%) cross-
validation with new variable selection in every CV run is one reliable validation procedure [79].  
Table 1. Positive and Negative Aspects in QSAR (a General Perspective)  
“Poor” QSAR “Good” QSAR 
Pathologies of “Poor” QSAR Models Related to 
High Dimensionality 
   
Artificial parameters 
Parameters with biophysical 
relevance 
Non-qualitative (biophysical) model; non-causal 
relationship; lack of interpretability 
Too many variables to select Few variables to select 
Chance correlations; overfitting; lack of 
interpretability 
Many variables in the model Few variables in the model 
Chance correlations; overfitting; lack of 
interpretability 
No test set predictivity (“Kubinyi 
paradox”) 
Leave-many-out cross-
validation 
Statistical Unicorns 
   
  
If the predictive ability of the model is not properly validated and it is based on variables lacking some 
structural or biophysical sense when using a high dimensional QSAR data, the probability of generating a 
statistically significant but unreliable QSAR models [80, 81, 83, 87, 88] will be very high. As suggested 
by Unger and Hansch [89] we may generate what they call “statistical unicorns”, that is, beasts that only 
exist on papers. As it can be noted, all four key elements to generate predictive, biophysically meaningful 
and interpretable QSAR models pass through dimensionality reduction and variable selection.  
3.2. Selection Methods for High-Dimensional Data in QSAR  
Variable selection, also known as feature selection, attribute selection or variable subset selection, is 
the process of selecting, from the whole set of variables, the most relevant ones, so that as much 
information as possible is contained in a reduced amount of variables or features. Hence, this phase will 
be crucial. Due to the large number of existing variable selection techniques, identifying the best one 
becomes a difficult task. For this reason, it is desirable for these techniques to be fast, automated, and 
applicable to large data sets of structurally diverse compounds. Automatic selection methods of the best 
descriptors for the construction of a QSAR model can be grouped into filtering, wrapper and hybrid 
methods [90].  
 
Filtering methods do not depend on the method used to build the QSAR model and consist of the 
following:  
 
 Correlation-based methods – based on the Pearson’s correlation coefficients in order to rule out the 
intercorrelated descriptors and consist in creating clusters of descriptors, for which correlation 
coefficients are higher than a certain threshold and retaining only one. This descriptor can be 
randomly chosen among the members of each cluster [91] or as a result of estimating the 
correlations between pairs of descriptors (if the estimation exceeds a threshold, it will be randomly 
done ruling out one of the descriptors). Nevertheless, it is important to note that this method could 
be applied only if the value of descriptors and experimental data are normally distributed [92].  
 Methods based on the Information Theory – the information content of the MD is defined in terms 
of the entropy of descriptor and treated as a random variable. The method defines various ranking 
measures, obtained from the information shared between two descriptors or between a descriptor 
and the activity such as the mutual information [93].  
 Statistical Criteria – can be used to rank the descriptors: the correlation between pairs of Fisher's 
ratio (ratio of the between class variance to the within-class variance) [94] or the quality of MD 
based on the Kolmogorov-Smirnov [95].  
 
Wrapper methods work linked to the mapping algorithm for the QSAR model building [96]. 
Therefore, the error of the mapping algorithm for a given subset measured, for example, using cross-
validation will be used to choose the best subset of descriptors. This group of variable selection methods 
contains the following:  
 
 Principal component analysis (PCA) [97], which is the dominant approach included in industrial 
applications, tries to obtain a new set of variables (referred to as principal components) that will 
describe the data in order of decreasing variance. PCA can be seen as a method used to determine 
the natural dimensionality of the dataset, allowing subsequent embedding of the data into a space 
of lower dimensionality within a margin of prescribed original variance percentage. This 
mathematical procedure converts a set of observations of possibly correlated variables into a set of 
values of uncorrelated variables by means of an orthogonal transformation. These variables are 
called principal components. Hence, with this procedure, the number of variables will be reduced. 
This selection method is used with the building of linear models with projections to latent 
structures by means of partial least squares (PLS) [98]. This can be extended to non-linear systems 
using neural networks or kernel-based methods such as support vector machines (SVM) [99].  
 Genetic algorithms (GA) [100] which, as it was previously showed, are efficient methods that 
mimic natural evolution by modeling a dynamic population of solutions. Chromosomes evolve by 
means of crossover and mutation, enhancing the survival and reproduction of the fittest ones. 
Choosing the initial population is an important aspect and it can be based on Shannon’s entropy 
combined with graph analysis [101].  
 Simulated annealing (SA) [102], which is another stochastic method designed for function 
optimization utilized in QSAR, and represents an evolutionary approach where the minimized 
function is the error of the model built using the subset of descriptors. This algorithm iteratively 
finds a new subset of descriptors obtained as a result of modifying the current-best one. 
Subsequently, this method decides whether to adopt the new solution as the current optimal 
solution or not, based on the evaluation of the new subset’s prediction error. Thus, the new 
solution will be selected if it leads to lower error rates than the current one. In addition, the worst 
solution can replace the current-best one by using a given probability, based on the Boltzmann 
distribution. This replacement allows this method to escape from local minima of the error 
function.  
 Sequential feature forward selection, which is a deterministic method implementing a search 
throughout the feature subsets [103]. First, a single feature that leads to the best prediction is 
selected. Then, each feature is individually added to the current subset and the errors of the 
resulting models are quantified. The feature that reduces the most the error is added to the subset. 
The selection will stop when a previously provided number of variables is reached or by 
incorporating an artificial random feature [104].  
 Sequential backward feature elimination [103], which is another sequential method that uses as a 
starting point the entire set of MDs. During each step eliminates one feature with the highest error 
until a specific number of MDs is obtained. Due to the time consuming disadvantage, a new 
method was proposed such as the recursive feature elimination for support vector machines (SVM) 
[105]. In this method, the learning method is executed once using all the features except one, 
choosing the feature to be removed based on these results.  
 
The hybrid methods use the fusion of the filtering and wrapper methods. The feature selection 
methods can also be included in the mapping methods that generate the final QSAR model. A hybrid 
method particularly suitable for genomic and biological datasets is the multiple inclusion criterion (MIC) 
[106]. This method is a simplification of stepwise feature selection which selects features that are helpful 
across multiple tasks and permits adding each feature to none, some or all the tasks. This method is 
particularly appropriate for selecting a small set of predictive features from a large set of potential ones. 
The next section of the review will shortly present the main QSAR methods used to obtain prediction 
models for specific properties/activities.  
3.3. Methods to Build QSAR Models  
After selecting the proper descriptors, the QSAR model can be constructed with a series of methods as 
a linear or non-linear function. Depending on the nature of the activity variable, the mapping methods are 
different. If the activity is a continuous value, the regression method will be used. In contrast, if the 
activity is categorical (i.e. inactive or active compounds) the resulting model will be defined by a decision 
boundary, separating the classes in the descriptor space.  
 
Linear methods have been used from the beginning of QSAR and are straightforwardly interpretable 
and adequately accurate for small datasets of similar compounds. The model function is a linear 
combination of the MDs as follows:  
 
 Multiple linear regression (MLR) [107, 108], are models in which the activity to be predicted is a 
linear function including all the descriptors and the coefficients of the function are estimated based 
on the training set. These free parameters are chosen to minimize the squares of the errors between 
the predicted and the current activity. However, MLR analysis presents some limitations: large 
descriptors-to-compounds ratio or multicollinear descriptors in general make the problem ill-
conditioned and make the results unstable.  
 Partial least squares (PLS) [109] linear regression is a technique that surmounts the problems 
existing in MLR related to multicollinear or over-abundant descriptors. This method assumes that 
despite the large number of descriptors, the modeled process is directed by a relatively small 
number of latent independent variables. PLS linear regression decomposes the input matrix of 
descriptors into scores and loadings with the aim of indirectly obtaining knowledge on the latent 
variables. The scores are orthogonal and they also allow predicting well the activity while they are 
able to capture the descriptor information [110, 111].  
 Linear discriminant analysis (LDA) [112] linearly transforms the original feature space into a new 
space that maximizes the interclass separability and minimizes the within-class variance. This 
technique works solving a generalized eigenvalue problem based on the between-class and within-
class covariance matrices. Hence, in order to avoid ill-conditioning of the eigenvalue problem 
[113, 114], there has to be a significantly smaller number of features than of observations.  
 
However, interpreting non-linear models is harder and there may be overfitting even though they 
become more accurate, in particular for large and diverse datasets. The main types are the following:  
 
 Bayes classifier, which is derived from the Bayes rule concerning the posterior probability of a 
class in relation to its overall probability, the probability of the observations and the probability of 
a class in relation to the observed variables [115, 116]. In this method, the predicted class 
corresponds to that one which minimizes the posterior probability. However, in real-world 
problems, these probabilities remain unknown, so they must be estimated. In other to overcome 
this, the probabilities of the classes in relation to the different descriptors are assumed to be 
independent. This is the basis of the naïve Bayes classifier (NBC) [117]. The Bayesian approach 
can be used to learn an optimal non-linear classifier and the most relevant subset of predictor 
variables (or features) regarding the classification task at the same time [118]. The approach 
presented by these authors utilizes heavy-tailed priors in order to promote sparsity in the usage of 
basis functions as well as features; these priors regulate the likelihood function, enhancing 
accurate classification of the training data. As a result, an expectation-maximization (EM) 
algorithm is obtained. This algorithm is capable of efficiently computing a maximum a posteriori 
(MAP) point estimate of the various parameters. This algorithm extends already existing sparse 
Bayesian classifiers, which can be seen as the Bayesian equivalent to support vector machines. 
Experiments involving kernel classifiers applied to several artificial and benchmark data sets 
showed parsimonious feature selection and excellent classification accuracy.  
 k-Nearest neighbor (k-NN) [119, 120] is a type of instance-based learning and can be conserided 
one of the simplest machine learning algorithms. It requires very little training, converging to the 
lowest prediction error when more training data is used. Each instance (in this case a compound in 
the descriptor space) will be classified based on the k closest training examples (in this case 
compounds) from the training set. Thus, the output of the algorithm, in this context, will be the 
activity class that is most highly represented among the k nearest neighbors [121, 122].  
 Artificial neural networks (ANN) [123, 124] which are prediction models inspired from biology, 
based on the architecture of a network of neurons. The most frequent ANNs are feed-forward 
networks, such as those based on perceptron or radial-basis function. In these networks, 
information flows in one single direction: from the input neurons to the output passing through a 
set of hidden layers [125, 127]. Two examples of ANNs are the followings:  
 The multi-layer perceptron (MLP) network is composed of interconnected perceptrons distributed 
in layers [128]. Each perceptron is able to linearly combine its input values, returning either a 
binary or continuous value as output, by means of a transfer function. It must be highlighted that 
each input of the perceptron has an associated weight that represents its relevance.  
 The radial-basis function (RBF) neural networks [129] are composed of three layers: an input 
layer, a hidden layer and an output layer. Unlike MLPs, the output obtained by the neurons 
belonging to the hidden layer is not calculated as the product of the weights and the input values. 
Each neuron of the hidden layer is characterized by its center and its output is computed as the 
distance between the input compound in the descriptor space and the neuron’s center.  
 Decision trees (DT) [130, 131] which are derived from logic-based and expert systems, where 
each classification tree corresponds to a set of predictive rules in Boolean logic [132].  
 Support vector machines (SVMs) [133] which are derived from the structural risk minimization 
principle, being the linear support vector classifier the most basic element. SVMs builds a 
hyperplane in a high- or infinite-dimensional space, that can be utilized for classification, 
regression, or other tasks [134]. The advantage of this model compared with ANNs is that the 
objective function is unimodal. Hence, this function can be efficiently optimized for the global 
optimum.  
 Evolutionary algorithms (EA) [35-37, 135] which are inspired by mechanisms of biological 
evolution such as selection, reproduction, recombination and mutation. Possible solutions to an 
optimization problem correspond to the individuals of a population, being the fitness function what 
characterizes the environment within which these solutions evolves [136]. Examples of these 
methods are the following: genetic algorithm, which can be considered the most popular type of 
EA, genetic programming (GP), evolutionary programming, evolution strategy and neuroevolution 
[137, 138]. The genetic function approximation (GFA) algorithm [139, 141] is an earlier strictly 
QSAR application of GP and it was conceived to be applied to the function approximation 
problem. When it receives a large number of potential factors influencing a response, including 
several powers and other functions of the raw inputs, it should obtain the subset of terms that 
correlates best with the response.  
 Ensemble methods which represent an approach to QSAR analysis focused on building a single 
predictive model; consists of bagging [142], random subspace [143] methods or boosting [144].  
 
The current review is focused on the description and applications of the evolutionary computation 
methods.  
3.4. Current Evolutionary Feature Selection Methods and Aplications in QSAR  
Evolutionary techniques have usually provided excellent results dealing with complex problems. One 
of the areas where these results are especially good is drug design. Different approaches are tested, but the 
most usual are related to two key tasks on the drug design process: combinatorial library design and 
deriving QSAR models. Combinatorial libraries are the result of combinatorial synthesis, with the goal of 
synthesizing large numbers of compounds in parallel. The main problem is the huge amount of 
compounds that could be synthesized, so it is not possible to check them individually. Thus, methods are 
required for selecting appropriate subsets of compounds. The large amount of possibilities involved 
requires a method to optimize the tests (preprocessing and selecting the compounds) and makes this 
problem ideal for applying approaches based on evolutionary algorithms.  
 
It is important to keep in mind that QSAR methods provide intelligible models by means of a relation 
between the structure and the activity of the molecule. One of the first approaches demonstrated that 
thermodynamic or electronic information could be used to explain the biological activity by means of a 
simple regression equation [2, 145]. Since this first approach has been stated by Hansch, several 
significant key-points happened: first, the availability of a large number of easily computable molecular 
compounds and, second, a great number of sophisticated techniques (i.e. evolutionary techniques) are 
available to improve the first linear regression approach. By using a large number of molecular 
descriptors, overfitting of the experimental data can result in QSAR models with poor predictive ability. 
Thus, the evolutionary algorithms have successfully been applied to select descriptors that give rise to 
good QSAR models [146].  
 
Feature selection can be based on two main approaches. The first option or forward-step methods 
starts with a unique descriptor and the rest of them are included (step by step) according to any kind of 
fitness evaluation. The process will stop when the addition of new descriptors does not improve the 
model. The second option, called backward-elimination, used an opposite approach. Here, all the 
descriptors are included in the first model and one of them is removed in each step of the method [147].  
 
Evolutionary techniques can be used to address this kind of optimization. First of all, as previously 
shown, a correct representation must be established. Using genetic algorithms, one of the most simple 
(and used) representations consists of a binary string where each bit represents a different feature 
(descriptor, compound). If the bit has a value of 1, the feature will be active (it is present), on the other 
hand if the bit has a value of 0, the feature will be inactive (it will not be used in the model). Using this 
representation and performing a least-squares regression to regenerate the coefficients, Rogers and 
Hopfinger [139] developed the genetic function approximation (GFA) method. It was successfully 
applied over the Selwood dataset, which has become a standard test for QSAR applications and contains 
31 compounds and 53 descriptors. Another approaches use genetic algorithms in combination with other 
techniques, such as artificial neural networks [148] to improve the search and the model building [136, 
149].  
 
The work published by Jalali-Heravi et al. [150] presents a new nonlinear feature selection technique 
called genetic algorithm-kernel partial least square (GA-KPLS). This technique takes advantage of the 
power of an optimization method (a genetic algorithm, GA) and the robustness of a nonlinear statistical 
method for variable selection (KPLS). Then, with the aim of obtaining a nonlinear QSAR model for 
substituted aromatic sulfonamide (such as carbonic anhydrase II inhibitors) activity prediction, the feature 
selection technique is combined with ANNs. It can be concluded from the results that this approach works 
well for performing variable selection in nonlinear systems.  
  
Hasegawa et al. [151] developed a GA-based PLS method, called GAPLS, to apply variable selection 
in QSAR studies. The modified genetic algorithm (GA) proposed by Leardi is capable of obtaining PLS 
models with high internal predictivity employing a reduced number of variables. The method was tested 
on data involving inhibitory activity of calcium channel antagonists with the objective of observing its 
performance for variable selection. This way, structural requirements for the inhibitory activity could be 
efficiently estimated by selecting variables that contribute significantly to it. Results show that the 
structural requirements nicely correspond to those derived by the MLR analysis, and the utility of GAPLS 
was demonstrated.  
 
A novel genetic algorithm guided selection technique (GAS) is described by Cho et al. [152]. In order 
to build a QSAR/QSPR model, a simple encoding scheme which can represent compound subsets and 
descriptors as variables is utilized. As part of this technique, a genetic algorithm is used to concurrently 
optimize these variables. Thus, this technique builds several models each applying to a subset of the 
compounds. The method is able to correctly identify artificial data points belonging to various subsets. 
The analysis of the XLOGP data set shows that the subset selection method can be useful in improving a 
QSAR/QSPR model when the variable selection method fails.  
 
Hasegawa et al. [153] designed a new variable selection method for comparative molecular field 
analysis (CoMFA) modeling (GARGS, genetic algorithm-based region selection). In order to assess 
whether the method was capable of identifying known molecular interactions in 3D space, GARGS was 
applied to a data set containing acetylcholinesterase (AChE) inhibitors. GARGS successfully gave the 
best model whose coefficient contour maps were consistent with the steric and electrostatic properties of 
the active site in AChE. GARGS may facilitate the prediction of binding affinities if one already has a 
series of compounds and assumes the same binding mode. Moreover, multivariate 3D-QSAR analysis can 
also be done using the GRID software. The amount of interaction field variables from GRID can be 
reduced and simplified by GARGS, and then the predictive 3D-QSAR model simulating the physical or 
chemical environment in receptor may be obtained.  
 
Pavan et al. [154] developed GA-VSS: genetic algorithm-variable subset selection. This method was 
designed to look for the best ranking models within an extensive set of variables. Order-ranking strategies 
appear to be a valuable instrument, both to explore the data and to obtain order-ranking models, a 
promising option to usual QSAR methods.  
 
A genetic programming approach is also available. In this case, a genetic programming individual will 
be a tree structure where the internal nodes will usually represent mathematical operators and the terminal 
nodes will represent variable and constant values. In QSAR problems these internal nodes will represent 
the sum, quadratic and cubic power operators whereas the terminal nodes will represent the molecular 
descriptors available for the dataset. The fitness function in both cases will be the same (or at least very 
similar). It will use the model encoded in the internal representation (bit string or tree structure) to get a 
perform value using linear regression or any other method to allow the evolutionary method assess the 
quality of the solution.  
 
Venkatraman et al. [155] proposed a novel approach for analyzing QSAR data based on genetic 
evolutionary algorithms coupled with information theoretic approaches such as mutual information. 
These approaches have been used to find near-optimal solutions to such multicriteria optimization 
problems. The applicability of the method is demonstrated using a highly skewed dataset. In particular, it 
has been shown that the method can be used to realize a logic circuit capable of predicting the structure-
function relationship.  
 
Shen et al. [156] perform variable selection in QSAR studies with MLR and PLS modeling utilizing 
the evolution algorithm (EA). In this study, the Cp statistic has been adapted and used as the objective 
function in the EA search for diverse combinations of molecular descriptors. The process described was 
employed for predicting aromatic amine carcinogenicity. The QSAR analysis shows satisfactory 
prediction performance for the proposed methodology.  
 
Genetic algorithms and genetic programming are the most used evolutionary techniques, but there are 
other useful natural computing algorithms. For example, ant colony optimization tries to imitate how ant 
colonies search food to look for a valid solution for the problem. In the QSAR field there are successful 
solutions based on this approach [157-159].  
  
Shamsipur et al. [160] presented an innovative approach for the use of external memory in ant colony 
optimization strategy. The approach was applied to the descriptor selection problem in quantitative 
structure-activity/property relationship studies. More specifically, the QSAR/QSPR studies involved rate 
constants of o-methylation of 36 phenol derivatives and activities of 31 antifilarial antimycin compounds. 
Results showed that the speed and the quality of the solution are enhanced in contrast to traditional ant 
colony system algorithms. The authors also established that numerous models with high statistical quality 
are constructed from a single run of the method, which can infer the structure-activity/property 
relationship more easily and more accurately.  
 
Patil et al. [161] present a filter/wrapper search method based on ant colony optimization 
(ACO)/random forest. This method goes across the search space and chooses a feature subset which can 
classify with high accuracy. The authors applied the proposed algorithm to four widely studied CoEPrA 
(Comparative Evaluation of Prediction Algorithms, http://coepra.org) datasets in order to observe its 
performance. They found that their method was capable of effectively obtaining small feature subsets 
with excellent classification accuracy. Therefore, they concluded that their method can be used to solve 
feature subset selection problems with a high level of confidence.  
 
There exist other approaches which are based on the social behavior of bird flocking or fish schooling 
named particle swarm optimization (PSO). Applications of this kind of algorithms within QSAR 
environments can be found in refs. [157, 162, 163].  
 
A modification of particle swarm optimization (PSO) was developed by Shen et al. [164]. The PSO 
algorithm was modified for its application to the discrete combinatorial optimization problem and to 
diminish the likelihood of falling into local optima. The proposed algorithm was designed to select 
variables in multiple linear regression (MLR) and partial least-squares (PLS) modeling and to predict 
antagonism of angiotensin II antagonists. Experimental results proved that this algorithm quickly 
converges towards the optimal solution and that it is a valuable tool for variable selection.  
 
Agrafiotis et al. [163] proposed a novel method for feature selection in QSAR and QSPR studies. The 
method is a modification of particle swarms that uses a binary encoding. It was applied to build 
parsimonious QSAR models based on feed-forward neural networks and was tested on three classical data 
sets from the QSAR literature. Results show that the method works as well as simulated annealing and 
that it is capable of obtaining better and more varied solutions given the same amount of simulation time.  
 
The greatest advantage of all this type of techniques is related to the intrinsic operation of 
evolutionary techniques. The same technique offers a pattern to encode the problem and a set of operators 
to guide the search. The most important aspect when using this kind of techniques is related to the idea 
that the user must know only a way to check if a solution is valid or not (and nothing about how the 
solution should be constructed), but there are also limitations. The most important one is derived from 
their own operation process. Evolutionary techniques offer (usually) excellent solutions to a given 
problem, but they neither explain why that solution is selected nor how it was made up.  
 
The application of evolutionary computation techniques to solve problems related to QSAR started in 
1980’s. The first application in this field used two methods based on genetic programming to find useful 
QSAR models [165]. One of them penalizes model complexity (that is, the depth of the trees that 
represents the solutions is limited) and it is designed to generate only one linear model. The second one 
employs a multiobjective optimization approach (in this case the fitness function tries to optimize more 
than one parameter at the same time: model fitting, total number of terms, etc.).  
 
Compared with the global optimization techniques [137], evolutionary algorithms present several 
advantages [135]:  
 
 They are conceptually simple.  
 Unlike other numerical techniques, which may be only appropriate for continuous values or other 
constrained sets, the performance of these algorithms does not depend on the representation.  
 Incorporating prior knowledge is easy, yielding a more efficient exploration of the state space of 
possible solutions.  
 Evolutionary algorithms can also be combined with more conventional optimization techniques 
(i.e. the combination of gradient minimization after primary search with an evolutionary algorithm 
to perform the fine tuning of weights of an evolutionary neural network) or it may involve 
applying other algorithms in parallel, such as hybridizing with simulated annealing.  
 Solutions can be simultaneously evaluated and only selection (which requires at least pair-wise 
competition) needs to be sequentially processed. Many global optimization algorithms, such as 
simulated annealing, do not allow implicit parallelism.  
 Traditional optimization methods do not present robustness against dynamic changes, usually 
requiring a complete restart in order to provide a solution (e.g. dynamic programming). In contrast, 
evolutionary algorithms can be utilized to adjust solutions to changing circumstances.  
 One of the greatest advantages of evolutionary algorithms is related to their capacity to deal with 
problems involving non-human experts. Even though human expertise should be used if available, 
it often proves unsuitable for automating problem solving routines.  
 
One of the first approaches using genetic algorithms can be found in Ref. [166] where the authors use 
the evolutionary approach to guide the analysis of high throughput screening data to conclude that the 
results indicate that genetic algorithms are a very effective variable selection approach for binary QSAR 
analysis. Therefore, genetic algorithms have been used for optimizing robust mathematical models such 
as Bayesian-regularized artificial neural networks and support vector machines applied to diverse drug 
design problems [167].  
 
A more specific application (due the datasets employed) consists of using the Genetic Algorithms and 
a similar technique called simulated annealing to obtain anti-tubercular activity prediction [168]. They 
make the previous variable selection that later will be used by different kind of neural networks to 
perform the QSAR modeling of quinoxaline compounds. The same schema of previous variable selection 
by means of Genetic Algorithms and later modeling with Kohonen neural networks is used in Ref. [169]. 
In the same work, Partial Least Square and Support Vector Machine are also used to construct different 
models for the Human Intestinal Absorption process.  
 
Taha et al. [170] employed genetic algorithms (GAs) and multiple linear regression to construct 
different QSAR models. Thus, the GA was used to improve pharmacophor moleding. Pan et al. [171] 
present a method for performing quantitative structure-based design using genetic algorithm optimization 
and backward elimination multidimensional regression to achieve/perform data reduction, QSAR model 
construction and identification of possible pharmacophore sites. Zaheer-ul-Haq et al. [172] use a genetic 
algorithm to perform CoMFA, which is used with CoMSIA to construct 3D-QSAR. The authors found 
this approach to be the best. Moreover, results prove that using a genetic algorithm for ligand-based and 
receptor-based modeling is a potent approach to build 3D-QSAR models. Thus, these data can be used to 
direct the optimization process for inhibition enhancement, which is important for drug discovery and 
Alzheimer’s disease development.  
 
A genetic algorithm was proposed by Asadollahi et al. [173] to improve the performance of partial 
least squares (PLS) modeling. In this work, several methods are compared, demonstrating the superiority 
of the GA-PLS approach in terms of prediction capacity. The in silico screening technique was applied to 
the proposed QSAR model and the structure and potency of new compounds were predicted. The 
generated models proved to be useful to estimate pIC50 of CXCR2 receptors for which no experimental 
data is available. The electron conformational-genetic algorithm (EC-GA) was used by Yanmaz et al. 
[174] to perform 4D-QSAR studies on a series of 87 penicillin analogues. In this algorithm, a matrix 
composed of electron structural parameters and interatomic distances was built to describe each 
conformation of the molecular system. A GA was used to identify the most relevant descriptors and to 
predict the theoretical activity of the training (74 compounds) and test (13 compounds, commercial 
penicillins) sets.  
 
Zhou et al. [175] proposed a new method that combines particle swarm optimization algorithm (PSO) 
and genetic algorithm (GA) to optimize the kernel parameters of support vector machine (SVM) and 
determine the optimized features subset in parallel. These authors applied their method to four peptide 
datasets for quantitative structure-activity relationship (QSAR) research. The structural and 
physicochemical characteristics of peptides from amino acid sequences were employed to represent 
peptides for QSAR. The results obtained in this work suggested that the method might be a valuable 
instrument in peptide QSAR and protein prediction research.  
  
Reddy et al. [176] investigated QSAR prediction models developed on a dataset of 170 HIV protease 
enzyme inhibitors. A hybrid-GA optimization technique is used for descriptor space reduction. QSAR 
prediction models were built using the previously selected descriptors. The approaches presented in this 
paper yield the QSAR with good prediction performance. The models obtained can be helpful to predict 
biological activity of new untested HIV protease inhibitors and virtual screening in order to identify new 
lead compounds.  
 
A novel inductive data mining method design to automatically generate decision trees from data 
(genetic programming tree, GPTree) is presented by Ma et al. [177]. In order to model the original 
continuous endpoint by adaptively finding appropriate ranges to describe the endpoints during the tree 
induction process, avoiding the need for discretization prior to tree induction and enabling the ordinal 
nature of the endpoint to be considered in the generated models, the YAdapt method is created as an 
extension of the GPTree approach. The methods developed in this work were applied to QSAR modeling 
to predict chemical eco-toxicity and to analyze a historical database for a wastewater treatment plant.  
 
Archetti et al. [178] used GP for a QSAR investigation of docking energy. Thus, the authors present a 
GP-based framework on which specific strategies can be built, proving to be a helpful tool for the 
problem. Experimental results obtained by GP are compared to those obtained by other “non-
evolutionary” machine learning methods (including support vector machines, artificial neural networks, 
linear and least square regression), confirming that the technique proposed shows potential in terms of 
accuracy of the proposed solutions, of generalization capacity and of the correlation between predicted 
and data and correct ones.  
 
Finally, Zhou et al. [179] developed GA-GP, which is an algorithm for dealing with all kinds of 
nonlinear function relationships using GP to create new individuals and GA to optimize them at the same 
time making, thus, full advantage of both techniques. The authors applied this algorithm in QSAR in the 
medicinal field. The results obtained show that GA-GP is better than ANN. Moreover, it was found that 
the expressions obtained by the method clearly express and explain QSAR of the medicine. Thus, GA-GP 
can have very wide applications in the medicinal field of the molecule design.  
4. FUTURE TRENDS: JOINT OR MULTI-TASK FEATURE SELECTION METHODS  
Improvement of the profile of a drug candidate involves finding the middle ground between several, 
usually competing objectives. As a matter of fact, the perfect drug should to have the maximum 
therapeutic efficacy, the maximum bioavailability, and the minimum toxicity, which shows the multi-
objective nature of the drug discovery and development process. The fine-tuning of the multiple criteria 
in hit-to-lead identification and lead optimization is considered to be an important achievement in the 
rational drug discovery process. The objective of this change of paradigm is the rapid identification and 
removal of candidate molecules that have a low probability of surviving later stages of discovery and 
development. This novel approach will decrease clinical attrition, and as a result, the global cost of the 
drug development process [80, 81, 180-188].  
 
Unfavorable absorption, distribution, metabolism and elimination (ADME) properties have been 
recognized as one of the main causes of failure for candidate molecules in drug development. 
Computational chemistry and informatics have had provable influence on synthesis and screening in drug 
discovery. Until recently, drug discovery was mainly linear: ADME/Tox and drug-likeliness were 
assessed only in later stages. Computational chemistry, jointly with high-throughput methods, has helped 
in making the process multi-dimensional, in combining the process for lead generation and optimization 
taking into account ADME/Tox and drug-likeliness. Nowadays, the majority of drugs are discovered 
through programs that start by identifying a biomolecular target of potential therapeutic value during 
biological studies.  
 
Lately, decisions taken during the identification of small-molecule modulators of protein function and 
the transformation these into high-content lead series, as they have far-reaching consequences later due to 
increasing downstream costs due to high clinical failures, have gained more attention [180]. Thus, a more 
flexible model is needed: the sequential process of identification, evaluation and refinement activities 
must change towards a more integrated parallel one.  
  
Although chemoinformatics has accomplished numerous achievements in diversity analysis, such as 
structure-activity relationship (SAR) and virtual screening during the last ten years, the authors of Ref. 
[181] also consider parallel optimization of potency, selectivity and ADMET properties using 
computational models is challenging. However, in silico ADMET models are not largely accepted as they 
are not robust enough and do not cover all the medicinal chemists’ concerns, but more than acceptable 
performance has been achieved in drug-likeliness, solubility and lipophilicity. According to this paper, 
potential users of ADMET models frequently cite them as non-significant because they are based on 
small sets of chemical compounds, as, paradoxically, the numerous pharmaceutical companies in which 
these same potential users work do not share their in-house experimental data. Another problem cited in 
this paper is that when the compounds under investigation are more diverse chemically, SAR models are 
less likely to exist and to be uncovered. In addition, the increase of the chemical space boundaries and the 
diversity of the investigated compounds will cause the information content of a SAR model (if it exists) to 
increase. Thus, the authors propose solving this problem by combining the mechanism-based approaches 
with other data mining approaches. Technologies such as HTS or combinatorial chemistry (CC) produce 
great amounts of data. Therefore, it could be said that current drug design is data-driven and the most 
important objective is to discover knowledge from raw data. This process takes the raw, experimental 
results from data mining and then transforms them into useful and understandable information, which is 
not typically retrieved by standard techniques.  
 
There is not any approach capable of predicting all the desired ADME properties. Nevertheless, 
identifying the most suitable one for modeling a specific property is challenging. Thus, physiologically-
based pharmacokinetic (PBPK) simulations that predict pharmacokinetic properties have been developed 
[182]. Existing simulations are often based on compound data obtained in vivo or in vitro. However, 
according to this paper, the results of predictive ADME models may be utilized, in the near future, as 
inputs to PBPK simulations, providing precise in silico prediction of PK properties from compound 
structure alone. Thus, compounds with unsuitable PK will be removed at the beginning of the drug 
discovery process and those designed with optimal properties will progress to development.  
 
Conventional chemistry will be integrated with data mining [183]. The integrated and iterative use of 
these techniques, together with the significant data from HTS (including ADME/Tox and drug-like 
property data), to make up models that can be used to prioritize further library screening and synthesis 
through virtual screening activities, already has noteworthy impact on lead discovery and exploration.  
 
In silico screening methods are incredibly beneficial to drug discovery, being fast as well as practical 
for a seamless integration into daily research routines. The researchers concluded that the hit rates of 
virtual screening are greater than those from random screening [184]. Thus, the development of fast 
feedback-driven methods, using either purely in silico vHTS or integrated in silico/in vitro engines, are 
expected to further enhance the impact of virtual screening in the drug discovery process. That virtual 
screening can be considered as a valuable instrument to enrich libraries and compound collections [80, 
81]. Preprocessing properly the compound database is of major importance and, for this purpose, stepwise 
procedures (filters, pharmacophore searches, docking and scoring, visual inspection) are the most 
effective. Fragment-based approaches show a great potential in lead structure search and optimization. 
HTS strategies are directed towards increasing the number of compounds per plate in order to augment 
the number of screens per day, but this exponential race is heading nowhere. For this reason, more effort 
has been put into finding a more rational design for chemical libraries in relation to diversity, drug-like 
behavior and reagent selection. Thus, due to the size of the problem, efficient drug discovery nowadays 
relies primarily on computational methods [185].  
 
Physiologically-based pharmacokinetic modeling is a step further to total modeling, describing the 
whole body by a number of anatomical compartments. If we want to understand the real limiting factors 
in drug action in the whole body, a stepwise multiple QSAR technique should be considered [186]. That 
is, each step in drug action should be analyzed using a quantitative method, thus permitting one to fully 
conceive an overall QSAR. There is little doubt that the introduction of pharmacokinetic parameters in 
QSAR is a step towards a more rational drug design, that is, in the development of drugs and chemicals 
with an optimal wanted effect and a certain acceptable toxicity-profile, both predicted and understood. 
However, pharmacokinetic parameters are only useful when used properly. The weakest point in de novo 
design is the reduced transferability of the scoring functions [187]. Another general issue is the artificial 
accessibility of the constructs. However, it is probable that the most developed techniques (part of hybrid 
methods) will continue to advance and become more broadly used in drug discovery. In 2000, the global 
estimated R&D cost per new drug was US$ 802 million [188]. Results were validated in many different 
manners by analyzing independently derived published data on the pharmaceutical industry. Including an 
estimate of the cost per approved new drug for R&D carried out after approval increases total R&D cost 
to approximately US$ 900 million. All these arguments put forward the need for approaches capable of 
integrating drug- or lead-likeness, toxicity and bioavailability criteria at early stages of the drug discovery 
process as an emergent issue [180-183]. That is, methods capable of taking into account additional criteria 
for the early simultaneous treatment of the most relevant properties, potency, safety, and bioavailability, 
determining the pharmaceutical profile of a drug candidate [165, 189-196].  
 
An interesting work presents two new methods based on GP [165] whose aim is to identify useful 
QSAR models that represent a compromise between model accuracy and complexity,. The first one, 
genetic QSAR (GPQSAR), penalizes model complexity. This method obtains only one linear model that 
represents an appropriate balance between the variance and the number of descriptors selected for the 
model. The second one, multi-objective genetic QSAR (MoQSAR), is based on multi-objective GP and 
shows a new point of view for QSAR. Another goal, called chemical desirability was added. This goal 
rewards those models that consist of descriptors which are easily interpretable by chemists. Thus, 
MoQSAR is capable of identifying models that are at least as good as models obtained by standard 
statistical approaches and, in addition, these models yield more chemical interpretability.  
 
De novo drug design implies searching an enormous space of possible, drug-like molecules to choose 
those that are more likely to become drugs by means of computational technology. Multi-objective 
evolutionary graph algorithm (MEGA) [193] is a novel multi-objective optimization de novo design 
algorithmic framework that can be used to design structurally diverse molecules fulfilling one or more 
objectives. This algorithm integrates evolutionary techniques with graph-theory to directly manipulate 
graphs and performs an efficient global search for potential solutions. MEGA was applied for designing 
molecules that selectively bind to a known pharmaceutical target using the ChillScore interaction score 
family. This algorithm is capable of obtaining structurally diverse candidate molecules that represent an 
extensive variety of compromises of the supplied constraints and thus can be used to support expert 
chemists “giving ideas”.  
 
The study of a new data mining technique for multi-objective optimization of chemical properties was 
presented and combines hierarchical classification and visualization of multidimensional data [194]. 
Recursive partitioning is modified to use averaged information gains for multiple objective variables as a 
quality-of-split criterion. As a result of this, a hierarchical classification tree model is obtained.  
 
The desirability theory, which is a recognized multi-criteria decision-making approach, was used to 
interpret prediction models with the aim of extracting useful information [189]. Applying the belief 
theory enabled quantifying the reliability of the predicted desirability of a compound according to two 
inverse and independent but complementary prediction approaches. This information has demonstrated of 
great utility as a ranking criterion in a ligand-based virtual screening study.  
 
Some authors proposed a multi-objective optimization algorithm developed for automated integration 
of structure- and ligand-based molecular design [190]. Guided by a genetic algorithm, this algorithm 
allowed detecting a number of trade-off QSAR models accounting for two independent goals at the same 
time: the first one leaded towards the best regressions among docking scores and biological affinities and 
the second one minimizes the atom displacements from a properly established crystal-based binding 
topology. Taking into account the concept of dominance, 3D QSAR alike models profiled the Pareto 
frontier and were designated as non-dominated solutions of the search space. K-means clustering was 
then applied to choose a representative subset of the available trade-off models.  
 
The multi-objective optimization (MOOP) method based on Derringer’s desirability function permits 
carrying out global QSAR studies taking into account at the same time the pharmacological, 
pharmacokinetic and toxicological profile of a set of molecule candidates [191]. The value of the 
technique is shown with its application to simultaneous optimization of the analgesic, anti-inflammatory 
and ulcerogenic properties of a library of fifteen specific compounds. The levels of the predictor variables 
producing in parallel the best possible compromise between these properties are found and used to design 
a set of novel optimized drug candidates. MOOP methods initiate a new philosophy to attain optimality 
on the basis of compromises among the diverse objectives. These methods are aimed at achieving the 
global optimal solution by optimizing various dependent properties concurrently. Pareto MOOP can 
handle each property independently. However, optimization tasks need reliable fitness functions that can 
be derived from QSAR models. In this sense, simple descriptions (as few molecular descriptors as 
possible) of each property are desired. Thus, a common subset of features (as few as possible) able to 
accurately describe the k properties determining the final pharmaceutical profile of a drug candidate 
would be an ideal result. The application of joint or multi-task feature selection methods based on 
evolutionary computation methods like Pareto MOOP could be a substantial advance in this sense [106, 
118, 197-204].  
 
The ranking method permits drug candidates with unknown pharmaceutical properties from 
combinatorial libraries according to the degree of resemblance with the formerly obtained optimal 
candidate [192]. Thus, filtering the most promising drug candidates of a library (the best-ranked 
candidates) is possible, that is, those with the best pharmaceutical profile. The authors also propose both a 
method to validate the ranking process a quantitative and a measure of the quality of a ranking, the 
ranking quality index. Results show that the combined use of the desirability-based methods of MOOP 
and the proposed ranking appears to be a precious instrument for rational drug discovery and 
development.  
 
The MOOP-DESIRE methodology and a variation of this was used to study the arylpiperazine 
derivates that could interact with 5-HT1A and 5-HT2A, serotonin receptor subtypes with the aim of 
designing more selective molecules for the 5-HT1A receptor [195]. It was shown that the model results are 
in conformity with the existing pharmacophore descriptions, assuring an appropriate structural correlation 
and demonstrating that the methodology is helpful for solving the selective drug design problem. In 
addition, a combined strategy-based on MOOP and ranking for the prioritization of HIV-1 NNRTIs hits 
with appropriate trade-offs between inhibitory efficacy over the HIV-1 RT and toxic effects over MT4 
blood cells was proposed [196]. A study comparing the sequential, parallel and multi-objective virtual 
screening showed that the multi-objective approach works better than the other approaches.  
 
Modeling data from candidate cancer biomarkers taking into account newly developed ideas by the 
machine learning community is considered [200]. More specifically, combined objectives of feature 
selection and classification are considered. Estimation procedures are developed for analyzing 
immunohistochemical profiles by means of the least absolute selection and shrinkage operator. These lead 
to innovative and flexible models and algorithms for compositional data analysis.  
 
A new method for simultaneous feature selection and classifier learning by means of a sparse 
Bayesian approach was proposed [201]. These two tasks are performed by optimizing a global loss 
function that includes a term related to the empirical loss and another function that represents a feature 
selection and regularization constraint on the parameters. To minimize this function, the Boosted Lasso 
algorithm is used, following the regularization path of the empirical risk associated with the loss function. 
An algorithm for the relevance vector machine (a well-known non-parametrical classification method) 
was also developed.  
 
The QSAR models for molecules have been extended to non-molecular systems and descriptors for 
microarrays, imaging, spectra, and new species discovery. A multi-task feature selection filter that obtains 
strength from auxiliary microarray classification data sets utilizes Kruskal-Wallis test on auxiliary data 
sets and ranks genes based on their aggregated p-values [199]. Expressions of the top-ranked genes are 
used as features to build a classifier on the target data set.  
 
The computerized system was preclinically evaluated in terms of robustness for breast lesion 
characterization on two breast magnetic resonance imaging (MRI) databases that were obtained by means 
of scanners from two different manufacturers [197]. Once a breast lesion has been identified by the 
radiologist, the system automatically performs segments the lesion and performs feature extraction, 
obtaining as a result an estimated probability of malignancy. A Bayesian neural network with automatic 
relevance determination for combined feature selection and classification was used.  
 
A hot topic is the potential use of Bayesian neural network (BNN) with automatic relevance 
determination (ARD) priors for combined feature selection and classification in computer-aided diagnosis 
(CAD) of medical imaging [202]. Simulations show that the ARD-BNN approach has the ability to select 
the optimal subset of features on the designed non-linear feature spaces on which the linear approach 
fails. Moreover, ARD-BNN has the ability to recognize features that have high ideal observer 
performance.  
  
A methodology for pre-processing spectra and extracting putatively meaningful features before 
applying feature selection and classification algorithms was developed and tested [203]. This 
methodology involves a HMM-based latent spectrum extraction algorithm for fusing the information 
from several replicate spectra obtained from a single tissue sample, a simple algorithm for baseline 
correction based on a segmented convex hull, a peak identification and quantification algorithm, and a 
peak registration algorithm to align peaks from multiple tissue samples into common peak registers.  
 
Another method proposes an automated feature selection and classification system which includes 
logistic regression with controlled false discovery rate with the aim of addressing the taxonomic research 
need impediment in new species discovery [198]. Unlike conventional taxonomic practice, the system 
proposed by these authors is capable of automatically selecting body shape features from specimen 
samples with landmarks that unite populations within species, as well as distinguishing among species. It 
also associates probabilities to classification accuracy using the selected features in new species 
identification.  
 
A recent work [204] has presented a genetic process for the selection of an appropriate set of features 
in a fuzzy rule-based classification system (FRBCS) and to automatically learn the whole database 
definition using a non-linear scaling function to adapt the fuzzy partition contexts and to determine an 
appropriate granularity for each of them. An ad-hoc data covering learning technique is used to obtain the 
rule base. The method utilizes a multi-objective genetic algorithm in order to obtain a good trade-off 
between accuracy and interpretability.  
5. CONCLUSION  
The virtual screening for new molecules with a specific pharmacokinetic activity is the first step in the 
drug design industry. This computational predictions help to avoid high cost and time-consuming 
experiments. The general process consists of building a mathematical model that correlate the molecular 
structure with a specific property/activity (QSAR models) by using molecular descriptors. Among the 
different and complex methods to select the proper variables and to build the best QSAR model, the 
evolutionary computation plays an essential role. The genetic algorithms provide excellent results by 
using the natural concept of the evolution. Evolutionary algorithm optimizers are global optimization 
methods and scale well to higher dimensional problems. They are robust with respect to noisy evaluation 
functions, and handling evaluation functions which do not yield a sensible result in a given period of time 
is straightforward. Its simplicity, flexibility, capacity to be mixed with other methods and accessibility to 
non-human experts make the evolutionary methods one of the best solutions in QSAR.  
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